Curcumin and Cognitive Health: Insights from Randomized Controlled Trials

View at publisher
Authors: Bhagavathi Sundaram Sivamaruthi, Chaiyavat Chaiyasut, Periyanaina Kesika
Cited by: 1

Abstract

Curcumin has garnered attention for its potential neuroprotective effects, attributed to its antioxidant and anti-inflammatory properties. This review summarizes the results of Randomized Controlled Trials (RCTs) evaluating the impact of curcumin supplementation on cognitive function in adults. Several studies have reported that curcumin supplementation could improve cognitive domains, including memory, attention, and processing speed. Nano-formulations of curcumin provide better bioavailability and improved bioactivities. Curcumin supplementation (Longvida®, Theracurmin®, and CurQfen®) has shown significant benefits for cognitive function in humans. Studies have reported improvements in working memory, attention, mood, and cerebral blood flow, particularly in older adults. Some trials also demonstrate reductions in neuroinflammatory markers and amyloid/tau deposition. However, results across studies are heterogeneous, potentially due to variations in curcumin formulations, dosages, study durations, and participant characteristics. In conclusion, curcumin shows promise as a cognitive enhancer in humans. However, further large-scale, standardized RCTs are necessary to establish optimal dosing strategies and confirm their efficacy across diverse populations.

Fields of Study & Subjects

Curcumin's Biomedical Applications Medicinal Plants and Neuroprotection Alzheimer's disease research and treatments

Publication details

Journal / source
Current Pharmaceutical Design
Publisher
Bentham Science Publishers Ltd.
Volume
32
Publication date
3 July 2026
Language
EN